Literature DB >> 3943630

Mechanism of o-aminophenol metabolism in human erythrocytes.

A Tomoda, J Yamaguchi, H Kojima, H Amemiya, Y Yoneyama.   

Abstract

o-Aminophenol was found to be rapidly metabolized to a brown compound in the presence of purified human oxy- and methemoglobin, coupled with the oxidation and reduction of these hemoglobins by o-aminophenol. The final product of o-aminophenol was identified as 2-aminophenoxazine-3-one, by using spectrophotometry and HPLC. The metabolism of o-aminophenol was also observed in human erythrocytes. The production rates of 2-aminophenoxazine-3-one in the cells were very fast, but these were strongly decreased by bubbling carbon monoxide into the cell suspension when intracellular hemoglobin was in the ferrous state. The production of 2-aminophenoxazine-3-one from o-aminophenol in the cells was completely suppressed by cyanide and azide when intracellular hemoglobin was in the ferric state. These results suggest that oxy- and methemoglobin are involved in metabolism of o-aminophenol to 2-aminophenoxazine-3-one in human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943630     DOI: 10.1016/0014-5793(86)80211-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  A novel phenoxazine derivative suppresses surface IgM expression in DT40 B cell line.

Authors:  Sanyang Gao; Tomoko Takano; Kiyonao Sada; Jinsong He; Chiseko Noda; Naoko Hori-Tamura; Akio Tomoda; Hirohei Yamamura
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Soil transformation of 2(3H)-benzoxazolone of rye into phytotoxic 2-amino-3H-phenoxazin-3-one.

Authors:  R W Gagliardo; W S Chilton
Journal:  J Chem Ecol       Date:  1992-10       Impact factor: 2.626

Review 3.  Prevention of carcinogenesis and development of gastric and colon cancers by 2-aminophenoxazine-3-one (Phx-3): direct and indirect anti-cancer activity of Phx-3.

Authors:  Akio Tomoda; Keisuke Miyazawa; Takafumi Tabuchi
Journal:  Int J Mol Sci       Date:  2013-08-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.